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Numerous studies have shown that innate and adaptive immunity, as well as humoral and cellular mechanisms, are crucial medi ators of renal tissue injury in glomerulo nephritis, which can lead to acute kidney injury, chronic kidney disease and endstage renal disease. A growing body of evidence suggests, however, that glomerular cells can affect their own fate in glomerulonephritis and are not simply passive victims of the inter action between destructive and protective leukocytes. Intrinsic renal cells can express receptors, such as CD40 or Tolllike receptor 4, and secrete signals, such as IL12 and tumour necrosis factor, that induce their own immune injury [1] [2] [3] [4] . Furthermore, athymic (nude) mice or rats that constitutively lack T cells still develop glomerulonephritis after anti glomerular basement membrane (GBM) serum injection 5, 6 . In their recent article, Luque and colleagues make a prominent contribution to these findings by showing that local renal expression of the cytokine receptor common subunit γ (γ c ) protects against antiGBM induced glomerulonephritis, independent of B cells, T cells and natural killer cells −/− mice, confirm ing that IL15 and IL2Rβ protect against nephrotoxic nephritis. Immunohistochemical staining showed that IL15 receptor subunit α (IL15Rα) and its coreceptors γ c and IL2Rβ were not expressed in healthy glomeruli in Rag2 −/− mice but that their expression was induced after injection of the nephrotoxic serum. In colocalization studies, γ c was expressed in podocytes in nephritic glomeruli. γ c was also expressed in renal biopsy samples from patients with crescentic glomerulo nephritis and colocalized with nephrin and synaptopodin in podocytes, whereas it was only weakly present in normal biopsy sam ples from renal transplant recipients. This finding confirms that podocyte expression of γ c is important in human disease, as well as in mouse models.
The researchers also showed that IL15 induced the phosphorylation of JAK1, JAK3 and spleen tyrosine kinase (SYK) in WT mouse primary podocytes in vitro, which is consistent with previous studies that showed IL15mediated was reduced, and in Rag2 −/− Il2rb −/− mice, which had no JAK1, JAK3 or SYK phos phorylation. These findings suggest that the protective effect of IL15 might be mediated by JAK and SYK activation, which con trasts with previous studies in which SYK inhibition with fostamatinib was protec tive in a Wistar Kyoto (WKY) rat model of nephrotoxic nephritis 8 . The researchers suggest that in this rat model, IL15 levels might be increased by offtarget effects of fostamatinib. This discrepancy between the different effects of SYK activation might stem from differences between the models, as WKY rats have a genetic susceptibility to glomerulo nephritis that is not present in other rat strains. Alternatively, the protective effect of SYK inhibition by fostamatinib in macrophages might outweigh the protective effect of SYK activation in renal cells. This second explanation would be consistent with studies of conditional Syk deletion in mye loid cells, which conferred protection against glomerular crescent formation, inflamma tion, fibrosis and decline in renal function in mouse nephrotoxic nephritis 9 . Further work is required to elucidate this question. Finally, the mechanism underlying the protective effect of IL15 is not clear. Quantification of the number of other immune cells such as neutrophils, monocytes, macrophages and natural killer cells in the glomerulus of knockout mice with nephritis would be useful.
Luque et al. report an exciting advance in the understanding of the pathophysiology of crescentic glomerulonephritis and shed light on how local renal cells can modulate their own damage through the direct action of cytokines, in addition to their established role in signalling within the host immune system. Their work provides comprehen sive and convincing evidence of a protective effect of γ c and IL15 expression in renal cells against nephrotoxic nephritis. These findings also suggest novel therapeutic strategies for glomerulonephritis such as modulation of the IL15 pathway. IL15Rα and IL15 com plexes are currently being tested as adoptive immuno therapy for cancer in vitro 10 . In the future, such advances could be adapted to enhance the protective effects of the IL15 pathway to treat glomerulonephritis.
